104 related articles for article (PubMed ID: 3026626)
21. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
22. High-dose carmustine for high-grade gliomas in childhood.
Bouffet E; Khelfaoui F; Philip I; Biron P; Brunat-Mentigny M; Philip T
Cancer Chemother Pharmacol; 1997; 39(4):376-9. PubMed ID: 9025780
[TBL] [Abstract][Full Text] [Related]
23. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.
Fine HA; Antman KH
Bone Marrow Transplant; 1992 Oct; 10(4):315-21. PubMed ID: 1330152
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
Takvorian T; Parker LM; Hochberg FH; Canellos GP
J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
[TBL] [Abstract][Full Text] [Related]
25. Effects of treatment on long-term survivors with malignant astrocytomas.
Imperato JP; Paleologos NA; Vick NA
Ann Neurol; 1990 Dec; 28(6):818-22. PubMed ID: 2178330
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
27. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
Mortimer JE; Hewlett JS; Bay J; Livingston RB
J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
[TBL] [Abstract][Full Text] [Related]
28. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.
Ghosh C; Lazarus HM; Hewlett JS; Creger RJ
J Neurooncol; 1992 Jan; 12(1):25-32. PubMed ID: 1311752
[TBL] [Abstract][Full Text] [Related]
29. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
30. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
[TBL] [Abstract][Full Text] [Related]
31. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial.
Recht L; Fram RJ; Strauss G; Fitzgerald TJ; Liepman M; Lew R; Kadish S; Sherman D; Wilson J; Greenberger J
Am J Clin Oncol; 1990 Apr; 13(2):125-31. PubMed ID: 2156417
[TBL] [Abstract][Full Text] [Related]
32. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
Comenzo RL; Hassoun H; Kewalramani T; Klimek V; Dhodapkar M; Reich L; Teruya-Feldstein J; Fleisher M; Filippa D; Nimer SD
Leukemia; 2006 Feb; 20(2):345-9. PubMed ID: 16319952
[TBL] [Abstract][Full Text] [Related]
33. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors.
Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E
Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.
van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I
Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
36. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
37. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
38. High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results.
Kessinger A
Neurosurgery; 1984 Nov; 15(5):747-50. PubMed ID: 6095134
[TBL] [Abstract][Full Text] [Related]
39. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
Kessinger A; Lemon HM; Foley JF
J Surg Oncol; 1978; 10(6):543-7. PubMed ID: 215846
[TBL] [Abstract][Full Text] [Related]
40. High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.
Rushing DA; Friedenberg WR; Baldauf MC; Broste S; Gehlsen JA; Kriesel DH; Koontz DP; Rodvold KA
Cancer; 1991 Aug; 68(4):720-4. PubMed ID: 1649684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
